does glp 1 help reduce inflammation GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal The Benefits of GLP-1 Therapy:

Because multi-receptor designs can influence several tissues at once, robust studies rely on integrated biomarker suites

Resources We Trust Cleveland Clinic: This Is How to Lose Weight the Right Way and Keep It Off Johns Hopkins Medicine: Maintaining Weight Loss Massachusetts General Hospital: Fitness for People Taking GLP-1 Agonists: A Comprehensive Guide WashU Medicine: Stopping GLP-1 Drugs Can Quickly Erase Cardiovascular Benefits Yale School of Medicine: What Is the Impact of GLP-1s in Older Adults With Obesity

Beyond the obesity data, the Phase 3 study ACHIEVE-1 in people with early type 2 diabetes over 40 weeks documented an HbA1c change of -1.24, -1.47, and -1.48 percentage points at 3, 12, and 36 mg, versus -0.41 percentage points under placebo (Fras et al., NEJM 2025)

2011;124:S318